查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370913

皮膚毒性測試市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按測試類型、測試方法類型（體內測試和體外測試）、最終用戶、地區、競爭細分

Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type, By Testing Method Type (In Vivo Testing and In Vitro Testing), By End User, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球皮膚毒性​​測試市場估值達到18.1億美元，預計在預測期內將強勁成長，預計年複合成長率（CAGR）為8.17%，預計到2022年將達到28.8億美元。2028. 皮膚毒性測試是一項綜合程序，旨在評估物質對人體皮膚的不利影響。該過程涉及對測試物質進行各種方案，從傳統的基於動物的方法到複製人類皮膚特徵的創新體外模型。其主要目的是識別皮膚接觸可能引起的任何刺激、過敏反應、致敏或全身毒性。皮膚毒性測試領域取得了重大進展，從依賴動物測試轉向更先進和人性化的方法。體外模型、3D 皮膚等效物和微流體平台正在徹底改變測試的準確性和效率。

主要市場促進因素：

  • 1.產業特定需求：產業特定需求對全球皮膚毒性​​測試市場的成長有重大影響。皮膚毒性測試對於產品安全評估至關重要，特別是在化妝品、藥品、化學物質和消費品等行業。不同行業遵守不同的產品安全和測試法規和指南。例如，化妝品行業必須遵守美國 FDA 或歐洲藥品管理局 (EMA) 等機構制定的法規。這些法規通常要求進行徹底的皮膚毒性測試，以確保產品成分的安全。隨著監管要求的發展，產業被迫採用先進的測試方法，推動市場成長。化妝品行業高度重視皮膚毒性測試，以確保護膚品、化妝品和個人護理用品不會引起皮膚不良反應。隨著消費者對天然和有機產品的需求不斷增加，對驗證產品安全性進行徹底測試的需求不斷成長，從而刺激了對創新皮膚毒性測試方法的需求。在製藥領域，皮膚毒性測試對於評估經皮給藥系統（例如貼片和乳霜）的安全性至關重要。隨著製藥公司開發新藥物和輸送機制，他們需要先進的測試方法來深入了解這些物質如何與皮膚相互作用，從而促進市場成長。涉及化學品的行業，包括工業、農業和家用化學品，必須確保其產品的安全，以保護工人和消費者。皮膚毒性測試對於確定與皮膚暴露相關的潛在風險至關重要。隨著工作場所安全和消費者健康意識的增強，這些行業的公司可能會投資更全面的測試方法，從而促進市場成長。
市場概況
預測期 2024-2028
2022 年市場規模 18.1億美元
2028 年市場規模 28.8億美元
2023-2028 年年複合成長率 8.17%
成長最快的細分市場 化妝品及個人護理
最大的市場 北美洲
  • 2.向非動物測試方法的轉變：向非動物測試方法的轉變極大地影響了全球皮膚毒性​​測試市場的成長。對動物福利、監管變化和技術進步的擔憂正在推動替代測試方法的採用，從而重塑市場的成長軌跡。世界各地的許多監管機構擴大提倡甚至強制要求在安全評估中使用非動物測試方法。例如，歐盟的 REACH（化學品註冊、評估、授權和限制）法規提倡採用動物試驗的替代方法進行化學品安全評估。監管機構認可並認可非動物方法，會激勵公司採用這些方法以維持合規性，從而促進市場成長。使用動物進行測試會引發道德問題，並對公司的聲譽產生負面影響。隨著大眾對動物福利意識的增強，消費者和利害關係人可能會青睞採用無殘忍檢測方法的公司，從而有可能促進市場成長。非動物測試方法，例如體外技術、重建人體皮膚模型和計算建模，在準確性和可靠性方面都得到了提高，使其成為傳統動物測試的可行替代方案。隨著科學界開發和驗證這些方法，尋求更具預測性和更有效率測試的行業傾向於採用它們，從而有助於市場擴張。向非動物測試方法的轉變鼓勵了毒理學領域的研究和創新，包括新技術和改進模型的開發。優先考慮創新並處於科學進步前沿的行業可能會投資這些方法，從而促進市場成長。
  • 3.技術創新：技術創新在影響全球皮膚毒性​​測試市場的成長中發揮關鍵作用。隨著技術的進步提供了更準確、更有效率和更具成本效益的測試方法，產業和監管機構擴大採用這些創新來確保產品安全。技術進步促進了複雜的體外測試方法的發展，該方法使用人類細胞、組織和 3D 模型來準確模擬皮膚反應。與傳統的動物測試相比，體外測試可以更相關、更可靠地代表人類反應，有助於尋求準確毒性評估的行業採用它。微流體和晶片器官技術使得能夠創造出模仿人體器官（包括皮膚）的結構和功能的微型設備。這些模型提供了一個受控環境來研究細胞對物質的反應，提供對毒性的即時洞察，並模擬物質與皮膚的相互作用，幫助危險識別和市場成長。高通量篩選 (HTS) 技術可以同時快速檢測多種物質，加快篩選過程並儘早識別潛在危害。各行業可以使用 HTS 來降低成本並縮短上市時間，有助於市場擴張。計算模型和人工智慧（AI）技術能夠根據分子結構和相互作用預測皮膚毒性，增強預測能力並減少大量實驗室測試的需要，從而促進市場成長。
  • 4.公眾意識和品牌聲譽：公眾意識和品牌聲譽對全球皮膚毒性​​測試市場的成長有重大影響。隨著消費者對產品安全和道德考慮的意識日益增強，以及品牌努力保持良好的聲譽，對全面皮膚毒性測試的需求不斷增加。在當今具有社會意識的世界中，消費者越來越關注道德實踐，包括動物福利和環境影響。優先考慮非動物測試方法並致力於道德產品開發的品牌可能會引起這些消費者的共鳴，從而推動對全面皮膚毒性測試的需求。大眾對產品相關潛在健康風險的認知促使消費者要求更安全、更透明的配方。進行徹底的皮膚毒性測試以確保產品安全的品牌可以贏得消費者的信任。透過嚴格的測試和準確的標籤解決消費者安全問題，品牌可以提高聲譽並培養客戶忠誠度。

主要市場挑戰：

  • 1.替代方法的驗證：替代方法的驗證可能會帶來挑戰，並可能阻礙全球皮膚毒性​​測試市場的成長。雖然替代方法因其倫理考量和科學進步而受到追捧，但其驗證過程可能複雜且耗時。替代方法的驗證需要廣泛的研究、資料收集以及與已建立的參考方法（通常包括動物測試基準）的比較。這個過程可能非常耗時且耗費資源，從而減慢了這些方法的採用速度，並可能阻礙市場成長。
  • 2.標準化問題：皮膚毒性測試缺乏標準化方案可能會導致測試結果不一致且可變，難以比較不同研究或實驗室之間的結果。這種不一致會削弱人們對測試方法可靠性的信心並阻礙市場成長。監管機構通常需要標準化的測試方案來確保結果的有效性和可重複性。缺乏標準化方法可能會使產品獲得監管批准的過程變得複雜，因為各機構可能會猶豫是否接受非標準化方法產生的資料。在缺乏標準化程序的情況下，不同的實驗室在測試相同物質時可能會產生不同的結果，從而造成差異，從而引起行業之間的關注。

主要市場趨勢：

  • 1.先進的體外模型：緊密複製人類皮膚生理學的先進體外模型在皮膚毒性測試市場中越來越受到重視。這些模型準確地模擬皮膚屏障功能、細胞相互作用和複雜的生物過程，為物質如何與人體皮膚相互作用提供更可靠的見解。使用動物進行測試引起了道德問題，各行業擴大轉向非動物方法。先進的體外模型透過消除動物測試的需要，同時仍提供具有科學意義的結果，提供了道德替代方案。監管機構正在認知到這些模型的價值，從而提高監管機構在滿足安全評估要求方面的接受度和採用率。與動物測試相比，體外模型提供更快的結果，使各行業能夠簡化測試流程並縮短上市時間。它們同時測試多種物質的能力提高了效率，使它們對尋求準確和高效毒性評估的行業具有吸引力。
  • 2.高通量篩選（HTS）：高通量篩選能夠同時測試多種化合物，在皮膚毒性測試市場中越來越受歡迎。 HTS 在產品週轉率高的行業中尤其有價值，因為它可以加快測試過程、縮短新產品的上市時間並最佳化資源利用率。傳統的毒性測試方法既耗時又昂貴，這使得 HTS 成為具有成本效益的測試的有吸引力的選擇。 HTS 快速產生大量資料，提供對潛在毒性的全面洞察並增強分析深度。它可以及早發現毒性問題，降低產品上市後昂貴召回或安全問題的風險。 HTS 可以涵蓋廣泛的毒性終點，包括皮膚刺激和致敏，這對於尋求全面安全評估的行業很有價值。

細分洞見：

  • 1.測試方法類型見解：體外測試預計在整個預測期內將大幅市場成長。體外模型在結構和功能方面非常模仿人類皮膚，從而可以更準確地進行毒性評估。體外方法的採用顯著減少了對傳統動物測試的依賴，符合倫理考慮以及科學研究中盡量減少動物使用的更廣泛趨勢。世界各地的監管機構越來越認知到體外測試方法、簡化核准流程和促進市場准入的價值。與動物測試相比，基於體外的測試方法通常可以提供更快的結果，從而可以在產品開發中更快地做出決策。
  • 2.最終用途洞察：化妝品和個人護理產品產業一直是市場的主導力量。該行業對安全的承諾正在推動皮膚毒性測試市場的擴大。投資這些測試方法的公司有助於這種成長並從中受益。該行業的創新動力促進了皮膚毒性測試方法的研究和開發，從而推動了更先進、更準確的測試技術的發展。優先考慮嚴格的皮膚毒性測試的公司可以建立植根於安全性和透明度的強大品牌聲譽，從而培養消費者的忠誠度和信任。

區域見解：

北美，特別是美國和加拿大，在 2022 年佔據市場主導地位。該地區擁有強大的研究基礎設施，促進創新皮膚毒性測試方法的開發和驗證。北美的主要製藥和化妝品行業推動了對徹底皮膚毒性測試的需求，因為他們優先考慮安全評估以滿足監管要求和消費者期望。這些產業的存在推動了先進技術的採用，北美的公司和機構在研發方面投入大量資金。這項投資支持尖端皮膚毒性測試方法的創建和驗證。資源和資金的可用性進一步促進了該地區新技術的發展和採用。北美化妝品、藥品和化學品等行業的競爭本質促使公司採用創新方法，包括先進的皮膚毒性測試方法，以確保產品的安全性和功效。該地區還受益於學術機構、研究組織和行業參與者之間的合作網路，促進知識共享、研究夥伴關係和標準化測試方法的發展。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球皮膚毒性​​測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按測試類型
    • 按測試方法類型
    • 按最終用戶
    • 按地區

第 6 章：北美皮膚毒性測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲皮膚毒性測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區皮膚毒性測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲皮膚毒性測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲皮膚毒性測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依測試類型（皮膚刺激測試、皮膚致敏測試）
    • 依測試方法類型（體內測試（基於動物的測試）和體外測試（基於細胞或基於組織的測試）
    • 按最終用戶（製藥業、化妝品和個人護理產品行業、化學工業及其他）
    • 按國家/地區
  • MEA：國家分析
    • 南非皮膚毒性測試
    • 沙烏地阿拉伯皮膚毒性測試
    • 阿拉伯聯合大公國皮膚毒性測試

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球皮膚毒性​​測試市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • SGS SA.
    • Covance, Inc
    • Bio-Rad Laboratories Inc.
    • Qiagen NV
    • GE Healthcare
    • Eurofins Scientific Inc
    • Merck KgaA
    • Thermo Fisher Scientific, Inc.
    • Charles River Laboratories International, Inc.
    • Catalent, Inc.

第 16 章：策略建議

簡介目錄
Product Code: 17199

The Global Dermal Toxicity Testing Market achieved a valuation of USD 1.81 Billion in 2022, and it is poised for robust growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.17% and is expected to reach USD 2.88 Billion by 2028. Dermal toxicity testing is a comprehensive procedure aimed at evaluating the adverse effects of substances on human skin. This process involves subjecting test substances to various protocols, ranging from traditional animal-based methods to innovative in vitro models that replicate human skin characteristics. Its primary objective is to identify any irritations, allergic reactions, sensitizations, or systemic toxicities that might arise from dermal exposure. The field of dermal toxicity testing has witnessed significant progress, transitioning from reliance on animal testing to more advanced and humane methods. In vitro models, 3D skin equivalents, and microfluidic platforms are revolutionizing the accuracy and efficiency of testing.

Key Market Drivers:

  • 1. Industry-Specific Demands: Industry-specific demands have a significant impact on influencing the growth of the global dermal toxicity testing market. Dermal toxicity testing is crucial for product safety evaluation, particularly in industries such as cosmetics, pharmaceuticals, chemicals, and consumer goods. Different industries adhere to distinct regulations and guidelines governing product safety and testing. For example, the cosmetics industry must comply with regulations set by authorities like the U.S. FDA or the European Medicines Agency (EMA). These regulations often mandate thorough dermal toxicity testing to ensure ingredient safety in products. As regulatory requirements evolve, industries are compelled to adopt advanced testing methods, driving market growth. The cosmetics industry places high importance on dermal toxicity testing to ensure that skincare products, makeup, and personal care items do not cause adverse skin reactions. With increasing consumer demand for natural and organic products, the need for thorough testing to verify product safety has grown, fueling demand for innovative dermal toxicity testing methods. In the pharmaceutical sector, dermal toxicity testing is essential for assessing the safety of transdermal drug delivery systems, such as patches and creams. As pharmaceutical companies develop new drugs and delivery mechanisms, they require advanced testing methodologies to gain insights into how these substances interact with the skin, contributing to market growth. Industries dealing with chemicals, including industrial, agricultural, and household chemicals, must ensure the safety of their products to protect workers and consumers. Dermal toxicity testing is crucial in determining potential risks associated with skin exposure. As awareness of workplace safety and consumer health increases, companies in these sectors are likely to invest in more comprehensive testing methods, contributing to market growth.
Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.81 Billion
Market Size 2028USD 2.88 Billion
CAGR 2023-20288.17%
Fastest Growing SegmentCosmetic & Personal Care
Largest MarketNorth America
  • 2. Transition to Non-Animal Testing Methods: The shift towards non-animal testing methods significantly influences the growth of the global dermal toxicity testing market. Concerns about animal welfare, regulatory changes, and technological advancements are driving the adoption of alternative testing methods, reshaping the market's growth trajectory. Many regulatory bodies worldwide are increasingly advocating for and even mandating the use of non-animal testing methods in safety assessments. For example, the European Union's REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation promotes alternative methods to animal testing for chemical safety evaluations. Regulatory authorities recognizing and endorsing non-animal methods motivate companies to adopt these methods to remain compliant, leading to market growth. The use of animals for testing raises ethical issues and can negatively impact a company's reputation. As public awareness of animal welfare grows, consumers and stakeholders may favor companies that employ cruelty-free testing methods, potentially boosting market growth. Non-animal testing methods, such as in vitro techniques, reconstructed human skin models, and computational modeling, have improved in accuracy and reliability, making them viable alternatives to traditional animal testing. As the scientific community develops and validates these methods, industries seeking more predictive and efficient testing are inclined to adopt them, contributing to market expansion. The shift toward non-animal testing methods encourages research and innovation in the field of toxicology, including the development of novel techniques and improved models. Industries that prioritize innovation and staying at the forefront of scientific advancements are likely to invest in these methods, fostering market growth.
  • 3. Technological Innovations: Technological innovations play a pivotal role in influencing the growth of the global dermal toxicity testing market. As advancements in technology offer more accurate, efficient, and cost-effective testing methods, industries and regulatory bodies are increasingly adopting these innovations to ensure product safety. Technological advancements have led to the development of sophisticated in vitro testing methods using human-derived cells, tissues, and 3D models that accurately simulate skin reactions. In vitro testing offers a more relevant and reliable representation of human responses compared to traditional animal testing, contributing to its adoption by industries seeking accurate toxicity assessments. Microfluidics and organ-on-a-chip technologies enable the creation of miniaturized devices that mimic the structure and function of human organs, including the skin. These models provide a controlled environment to study cellular responses to substances, offer real-time insights into toxicity, and simulate substance-skin interactions, aiding hazard identification and market growth. High-throughput screening (HTS) technologies allow for the rapid testing of numerous substances simultaneously, accelerating the screening process and enabling early identification of potential hazards. Industries can use HTS to reduce costs and time-to-market, contributing to market expansion. Computational modeling and artificial intelligence (AI) techniques enable the prediction of dermal toxicity based on molecular structures and interactions, enhancing predictive capabilities and reducing the need for extensive lab testing, fostering market growth.
  • 4. Public Awareness and Brand Reputation: Public awareness and brand reputation exert significant influence on the growth of the global dermal toxicity testing market. As consumers become increasingly conscious of product safety and ethical considerations, and as brands strive to maintain positive reputations, the demand for comprehensive dermal toxicity testing rises. In today's socially conscious world, consumers are increasingly concerned about ethical practices, including animal welfare and environmental impact. Brands that prioritize non-animal testing methods and demonstrate a commitment to ethical product development are likely to resonate with these consumers, driving demand for comprehensive dermal toxicity testing. Public awareness of potential health risks associated with products has led consumers to demand safer and more transparent formulations. Brands that conduct thorough dermal toxicity testing to ensure product safety can build trust with consumers. By addressing consumer safety concerns through rigorous testing and accurate labeling, brands can enhance their reputation and foster customer loyalty.

Key Market Challenges:

  • 1. Validation of Alternative Methods: The validation of alternative methods can pose challenges and potentially hinder the growth of the global dermal toxicity testing market. While alternative methods are sought after due to their ethical considerations and scientific advancements, their validation process can be complex and time-consuming. The validation of alternative methods requires extensive research, data collection, and comparison to established reference methods, often including animal testing benchmarks. This process can be time-consuming and resource-intensive, slowing down the adoption of these methods and potentially hindering market growth.
  • 2. Standardization Issues: The lack of standardized protocols in dermal toxicity testing can lead to inconsistent and variable test results, making it difficult to compare findings between different studies or laboratories. Such inconsistencies can undermine confidence in the reliability of test methods and hinder market growth. Regulatory agencies often require standardized testing protocols to ensure the validity and reproducibility of results. The absence of standardized methods can complicate the process of obtaining regulatory approvals for products, as agencies might be hesitant to accept data generated from non-standardized approaches. In the absence of standardized procedures, different laboratories might produce different results when testing the same substance, causing variability that can raise concerns among industries.

Key Market Trends:

  • 1. Advanced In Vitro Models: Advanced in vitro models that closely replicate human skin physiology are gaining prominence in the dermal toxicity testing market. These models accurately simulate skin barrier function, cellular interactions, and complex biological processes, providing more reliable insights into how substances interact with human skin. The use of animals for testing raises ethical concerns, and industries are increasingly turning to non-animal methods. Advanced in vitro models offer an ethical alternative by eliminating the need for animal testing while still providing scientifically meaningful results. Regulatory bodies are recognizing the value of these models, leading to increased regulatory acceptance and adoption in fulfilling safety assessment requirements. In vitro models offer quicker results compared to animal testing, allowing industries to streamline their testing processes and reduce time-to-market. Their ability to test multiple substances simultaneously enhances efficiency, making them attractive to industries seeking accurate and efficient toxicity assessments.
  • 2. High-Throughput Screening (HTS): High-throughput screening, which enables the simultaneous testing of multiple compounds, is gaining traction in the dermal toxicity testing market. HTS is particularly valuable in industries with high product turnover rates, as it accelerates the testing process, reduces time-to-market for new products, and optimizes resource utilization. Traditional toxicity testing methods can be time-consuming and expensive, making HTS an appealing option for cost-effective testing. HTS generates a large amount of data quickly, providing comprehensive insights into potential toxicity and enhancing the depth of analysis. It allows early detection of toxicity issues, reducing the risk of costly recalls or safety problems after a product's launch. HTS can encompass a wide range of toxicity endpoints, including skin irritation and sensitization, making it valuable for industries seeking comprehensive safety evaluations.

Segmental Insights:

  • 1. Testing Method Type Insights: In Vitro Testing is expected to witness substantial market growth throughout the forecast period. In vitro models closely mimic human skin in terms of structure and function, resulting in more accurate toxicity assessments. The adoption of in vitro methods significantly reduces the reliance on traditional animal testing, aligning with ethical considerations and the broader trend of minimizing animal usage in scientific research. Regulatory agencies worldwide are increasingly acknowledging the value of in vitro testing methods, streamlining approval processes and facilitating market access. In vitro-based testing methods often offer faster results compared to animal testing, allowing for quicker decision-making in product development.
  • 2. End Use Insights: The Cosmetics and personal care products industry segment has been the dominant force in the market. The industry's commitment to safety is driving the expansion of the dermal toxicity testing market. Companies investing in these testing methodologies contribute to and benefit from this growth. The industry's drive for innovation fosters research and development in dermal toxicity testing methods, leading to the evolution of more advanced and accurate testing technologies. Companies that prioritize rigorous dermal toxicity testing can build a strong brand reputation rooted in safety and transparency, fostering consumer loyalty and trust.

Regional Insights:

North America, specifically the United States and Canada, dominated the market in 2022. The region boasts robust research infrastructure, facilitating the development and validation of innovative dermal toxicity testing methods. Major pharmaceutical and cosmetics industries in North America drive the demand for thorough dermal toxicity testing, as they prioritize safety assessments to meet regulatory requirements and consumer expectations. The presence of these industries fuels the adoption of advanced technologies, and companies and institutions in North America invest heavily in research and development. This investment supports the creation and validation of cutting-edge dermal toxicity testing methods. The availability of resources and funding further facilitates the growth and adoption of new technologies in the region. The competitive nature of industries like cosmetics, pharmaceuticals, and chemicals in North America drives companies to adopt innovative approaches, including advanced dermal toxicity testing methods, to ensure product safety and efficacy. The region also benefits from collaborative networks between academic institutions, research organizations, and industry players, facilitating knowledge sharing, research partnerships, and the development of standardized testing methods.

Key Market Players

  • SGS S.A..
  • Covance, Inc
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • GE Healthcare
  • Eurofins Scientific Inc
  • Merck KgaA
  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.

Report Scope:

In this report, the Global Dermal Toxicity Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermal Toxicity Testing Market, By Test Type:

  • Skin Irritation Tests
  • Skin Sensitization Tests

Dermal Toxicity Testing Market, By Testing Method Type:

  • In Vivo Testing (Animal-Based Tests)
  • In Vitro Testing (Cell-Based or Tissue-Based Tests)

Dermal Toxicity Testing Market, By End User:

  • Pharmaceuticals industries
  • Cosmetics and personal care products industry
  • Chemical Industry
  • Other

Dermal Toxicity Testing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Dermal Toxicity Testing Market.

Available Customizations:

  • Global Dermal Toxicity Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermal Toxicity Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 5.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 5.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Test Type
    • 5.3.2 By Testing Method Type
    • 5.3.3 By End User
    • 5.3.4 By Region

6. North America Dermal Toxicity Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 6.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 6.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermal Toxicity Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Testing Method Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Dermal Toxicity Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Testing Method Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Dermal Toxicity Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Testing Method Type
        • 6.3.3.2.3. By End User

7. Europe Dermal Toxicity Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 7.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 7.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Dermal Toxicity Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Testing Method Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Dermal Toxicity Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Testing Method Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Dermal Toxicity Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Testing Method Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Dermal Toxicity Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Testing Method Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Dermal Toxicity Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Testing Method Type
        • 7.3.5.2.3. By End User

8. Asia-Pacific Dermal Toxicity Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 8.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 8.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Dermal Toxicity Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Testing Method Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Dermal Toxicity Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Testing Method Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Dermal Toxicity Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Testing Method Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Dermal Toxicity Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Testing Method Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Dermal Toxicity Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Testing Method Type
        • 8.3.5.2.3. By End User

9. South America Dermal Toxicity Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 9.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 9.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Dermal Toxicity Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Testing Method Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Dermal Toxicity Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Testing Method Type
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Dermal Toxicity Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Testing Method Type
        • 9.3.3.2.3. By End User

10. Middle East and Africa Dermal Toxicity Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
    • 10.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
    • 10.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Dermal Toxicity Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Testing Method Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Dermal Toxicity Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Testing Method Type
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Dermal Toxicity Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Testing Method Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Dermal Toxicity Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 SGS S.A..
    • 15.6.2 Covance, Inc
    • 15.6.3 Bio-Rad Laboratories Inc.
    • 15.6.4 Qiagen N.V.
    • 15.6.5 GE Healthcare
    • 15.6.6 Eurofins Scientific Inc
    • 15.6.7 Merck KgaA
    • 15.6.8 Thermo Fisher Scientific, Inc.
    • 15.6.9 Charles River Laboratories International, Inc.
    • 15.6.10 Catalent, Inc.

16. Strategic Recommendations